Add BrightSurf on Google Email

Evaluation of plasma neurodegenerative biomarkers for diagnosing minimal hepatic encephalopathy and predicting overt hepatic encephalopathy in Chinese patients with hepatic cirrhosis

This study investigated the performance of plasma neurodegenerative biomarkers (NfL, GFAP, tau, and UCHL1) in diagnosing minimal hepatic encephalopathy (MHE) and predicting overt hepatic encephalopathy (OHE) in Chinese patients with hepatic cirrhosis. The results showed that a combination of NfL, GFAP, tau, and UCHL1 was effective in d...

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateJan 16, 2025

Unlocking proteostasis: A new frontier in the fight against neurodegenerative diseases like Alzheimer's

Researchers have discovered a nucleolar complex that plays a pivotal role in maintaining cellular health through protein homeostasis, allowing for the dramatic reduction of toxic effects of Alzheimer's-causing proteins. This breakthrough offers hope for new therapies to slow or prevent neurodegenerative diseases, promoting healthy aging.

SourceThe Hebrew University of Jerusalem·JournalNature Cell Biology·TypeExperimental study·DateJan 3, 2025

New research identifies key cellular mechanism driving Alzheimer’s disease

Researchers have unveiled a critical mechanism linking cellular stress in the brain to Alzheimer's disease progression, highlighting microglia as central players in both protective and harmful responses. The study reveals that blocking a specific stress pathway reverses symptoms of Alzheimer's disease in preclinical models.

SourceAdvanced Science Research Center, GC/CUNY·JournalNeuron·TypeExperimental study·DateDec 23, 2024

Brain inflammation alters behaviour according to sex

Researchers found that neuroinflammation in the hippocampus significantly alters motivation and behaviour in mice, particularly in females. This study suggests that treatments targeting hippocampal neuroinflammation could help reduce cognitive and behavioural symptoms in diseases such as Alzheimer's and Depression.

SourceUniversity of Technology Sydney·JournalBrain Behavior and Immunity·TypeExperimental study·DateDec 18, 2024

Study reveals lasting effects of common herbicide on brain health

A new study reveals that glyphosate exposure in mice can cause lasting brain inflammation and accelerate Alzheimer's disease-like pathology, even after a significant pause from exposure. The herbicide's byproducts have been found to accumulate in brain tissue, raising serious concerns about its safety for human populations.

SourceArizona State University·JournalJournal of Neuroinflammation·TypeExperimental study·DateDec 4, 2024

Unlocking the mysteries of the brain

Scientists at Purdue University have identified new molecular markers for neurodegenerative diseases by analyzing protein behavior with age. The study sheds light on how phosphorylation causes protein aggregation, a hallmark of these diseases.

SourcePurdue University·JournalMolecular & Cellular Proteomics·DateNov 22, 2024

Labeling cell particles with barcodes

Researchers at the University of Tokyo have developed a new CRISPR-based system to label small extracellular vesicles (sEVs) with RNA barcodes, enabling comprehensive analysis of their biogenesis and release regulators. This system allows for the simultaneous study of thousands of genes and estimation of sEV release from host cells.

SourceUniversity of Tokyo·JournalNature Communications·TypeExperimental study·DateNov 19, 2024

New study highlights physician perspectives on emerging anti-amyloid treatments for Alzheimer’s disease in Israel

A new Israeli study explores physician attitudes toward emerging anti-amyloid treatments for Alzheimer's disease. Key findings highlight the need for multidisciplinary collaboration to address financial and logistical barriers, emphasizing education, cost-benefit analysis, and improved insurance coverage.

SourceIOS Press·JournalJournal of Alzheimer’s Disease·TypeMeta-analysis·DateNov 19, 2024

One gene provides diagnoses for 30 patients whose condition was unexplained for years

A team of researchers has identified 30 patients with previously undiagnosed conditions, linking them to rare mutations in the FLVCR1 gene. The study reveals a range of severe developmental disorders, including anemia and bone malformations, which share similarities with mice lacking the Flvcr1 gene and Diamond-Blackfan anemia.

SourceBaylor College of Medicine·JournalGenetics in Medicine·TypeData/statistical analysis·DateNov 8, 2024

Recreating a hallmark of Parkinson's disease in human neurons

Researchers create Lewy bodies in living dopaminergic neurons using human stem cells and find that immune challenge is crucial for their formation. The study identifies a previously unknown link between the immune system and neurological disease, suggesting that genetic predisposition may not be necessary for Parkinson's development.

SourceMcGill University·JournalNature Neuroscience·TypeExperimental study·DateOct 8, 2024

Promising ‘first’ in Alzheimer’s drug development

Researchers have developed a peptide inhibitor called RI-AG03 that effectively prevents Tau protein aggregation in lab and fruit fly studies. The breakthrough targets both major aggregation-promoting 'hotspots' of the Tau protein, potentially paving the way for more effective treatments for neurodegenerative diseases.

SourceLancaster University·JournalAlzheimer s & Dementia·TypeExperimental study·DateOct 3, 2024

New molecules from IOCB Prague decrease appetite and protect the brain against Alzheimer’s-type diseases

Scientists at IOCB Prague have developed a new compound that suppresses appetite and protects the brain against Alzheimer's disease. The modified molecule, derived from the neuropeptide CART, is effective in reducing pathology associated with Alzheimer's.

SourceInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague)·JournalEuropean Journal of Pharmacology·TypeExperimental study·DateAug 21, 2024

Science in Space to Cure Disease on Earth—the International Space Station National Lab and NASA announce new funding opportunity

The International Space Station National Laboratory is collaborating with NASA to fund up to $4 million in research addressing significant diseases like cancer, cardiovascular disease, and neurodegenerative disease. The joint solicitation aims to leverage microgravity to improve existing or develop new technologies for health problems ...

ALS diagnosis and survival linked to metals in blood, urine

A University of Michigan-led study found that higher levels of metals in blood and urine are associated with a greater risk for ALS and shorter survival. Occupational exposure to metals was also linked to increased metal levels, emphasizing the need for accounting for environmental factors when evaluating overall exposure risk.

SourceMichigan Medicine - University of Michigan·JournalJournal of Neurology Neurosurgery & Psychiatry·TypeData/statistical analysis·DateAug 6, 2024